Ipertrofan

Mepartricin, the active ingredient in Ipertrofan, is an anthelmintic presented as an oral tablet for oral use. It belongs to the macrocyclic lactone class and exhibits broad‑spectrum activity against intestinal nematodes and cestodes, treating infections in both adult and pediatric patients.

GNH USA supplies Ipertrofan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mepartricin is an anthelmintic that targets parasitic helminths in the gastrointestinal tract.

- Ascariasis: eradicates Ascaris lumbricoides infection, reducing worm burden and associated symptoms. - Hookworm infection: eliminates Ancylostoma duodenale and Necator americanus, improving anemia and gastrointestinal discomfort. - Trichuriasis: clears Trichuris trichiura infestation, alleviating abdominal pain and dysentery. - Chronic prostatitis/chronic pelvic pain syndrome: may reduce inflammatory symptoms and improve quality of life in affected males.

Mepartricin may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Nausea: mild stomach upset or queasiness. - Abdominal pain: cramping or discomfort in the abdomen. - Diarrhea: loose stools occurring during or after treatment. - Headache: transient mild to moderate headache.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or jaundice indicating liver injury. - Allergic reactions: rash, itching, swelling, or anaphylaxis in susceptible individuals. - Severe neutropenia: marked reduction in white blood cells, increasing infection risk.

Before prescribing Mepartricin, clinicians should consider several precautionary measures to ensure safe use. - Hypersensitivity: avoid use in patients with known allergy to mepartricin or related macrocyclic lactones. - Liver disease: use with caution in patients with hepatic impairment; monitor liver function tests. - Pregnancy: insufficient data; avoid unless potential benefit justifies potential risk. - Pediatric use: dosage and safety not established for children under 2 years; use only under specialist supervision. - Drug interactions: review concomitant medications for potential interactions (see interaction section). - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight in original packaging.

Mepartricin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Concurrent anthelmintics: combined use may increase neurotoxicity and risk of severe adverse reactions. - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - CYP450 substrates: mepartricin may inhibit certain enzymes, altering plasma levels of drugs metabolized by CYP3A4. - Antacids containing aluminum or magnesium: may reduce absorption of mepartricin, decreasing therapeutic effect. - CNS depressants: additive sedative effects possible; monitor patient for excessive drowsiness.